Clinical Trial

A Study to Investigate Safety, Reactogenicity, and Immunogenicity of mRNA-1365 (Profile 2) in Older Healthy Adults

Name: A Study to Investigate Safety, Reactogenicity, and Immunogenicity of mRNA-1365 (Profile 2) in Older Healthy Adults — clinical trial record (NCT07764237)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

The main objective of this trial is to evaluate the safety, reactogenicity, and immunogenicity of study interventions across intervention groups

Trial Details

NCT Number	NCT07764237
Lead Sponsor	ModernaTX, Inc.
Conditions	Respiratory Syncytial Virus (RSV), Human Metapneuomovirus (hMPV)
Enrollment	375 participants
Start Date	2026-08-16
Primary Completion	2027-07-20 (estimated)
Study Completion	2027-07-20 (estimated)
Updated on ClinicalTrials.gov	2026-08-13